Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dachengqi Decoction and Probiotic L92 for Severe Abdominal Hypertension
NCT04517045Phase 3Unknown
- Sponsor
- Xinhua Hospital
- Start
- Oct 2020
- Primary completion
- Jul 2022
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 3 trial of Dachengqi Decoction, Lactobacillus acidophilus L-92 in Intra-abdominal hypertension (IAH), sponsored by Xinhua Hospital. Status: unknown.
02
Drugs
Dachengqi DecoctionLactobacillus acidophilus L-92
03
Conditions
Intra-abdominal hypertension (IAH)
Beyond the preview
Go deeper on NCT04517045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04517045.